SilicoLife designs optimized microorganisms and novel pathways for industrial biotechnology applications.
SilicoLife has raised $10.4M in total funding. The most recent round was Series A. The last funding was announced in December 2022.
SilicoLife's investors include EISMEA, BlueCrow Capital.
SilicoLife is headquartered in Braga, Portugal.
SilicoLife designs optimized microorganisms and novel pathways for industrial biotechnology applications.
SilicoLife is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SilicoLife — Funding & Investors." VCBacked, December 13, 2022, https://www.vcbacked.co/company/silicolife. Accessed August 15, 2026.
VCBacked. (2022). SilicoLife — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/silicolife
{{cite web |title=SilicoLife — Funding & Investors |url=https://www.vcbacked.co/company/silicolife |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated